These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy. Kung AW, Michon J, Tai KS, Chan FL. Thyroid; 1996 Oct; 6(5):381-4. PubMed ID: 8936659 [Abstract] [Full Text] [Related]
26. Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy. Stan MN, Garrity JA, Bradley EA, Woog JJ, Bahn MM, Brennan MD, Bryant SC, Achenbach SJ, Bahn RS. J Clin Endocrinol Metab; 2006 Dec; 91(12):4817-24. PubMed ID: 16984988 [Abstract] [Full Text] [Related]
27. Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens. Otto EA, Ochs K, Hansen C, Wall JR, Kahaly GJ. J Clin Endocrinol Metab; 1996 Aug; 81(8):3045-50. PubMed ID: 8768872 [Abstract] [Full Text] [Related]
28. Protracted hypofractionated radiotherapy for Graves' ophthalmopathy: a pilot study of clinical and radiologic response. Cardoso CC, Giordani AJ, Wolosker AM, Souhami L, Manso PG, Dias RS, Segreto HR, Segreto RA. Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):1285-91. PubMed ID: 21550180 [Abstract] [Full Text] [Related]
29. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study. Howarth D, Epstein M, Lan L, Tan P, Booker J. Eur J Nucl Med; 2001 Oct 01; 28(10):1489-95. PubMed ID: 11685491 [Abstract] [Full Text] [Related]
30. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. Prummel MF, Mourits MP, Berghout A, Krenning EP, van der Gaag R, Koornneef L, Wiersinga WM. N Engl J Med; 1989 Nov 16; 321(20):1353-9. PubMed ID: 2519530 [Abstract] [Full Text] [Related]
31. Quantitative evaluation of extraocular muscle with high-field magnetic resonance in patients with Graves' ophthalmopathy with upper-lid retraction. Chen Y, Jin ZY, Zhang ZH, Xu DD, Meng W, Jiang B, Fang HY, Sun ZY, Chen Y, Sun HY, Feng F. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct 16; 34(5):461-7. PubMed ID: 23134821 [Abstract] [Full Text] [Related]
35. A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy. Campi I, Vannucchi GM, Minetti AM, Dazzi D, Avignone S, Covelli D, Currò N, Ratiglia R, Guastella C, Pignataro L, Beck-Peccoz P, Salvi M. Ophthalmology; 2013 May 16; 120(5):1092-8. PubMed ID: 23399378 [Abstract] [Full Text] [Related]
36. An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy. Teng CS, Crombie AL, Hall R, Ross WM. Clin Endocrinol (Oxf); 1980 Dec 16; 13(6):545-51. PubMed ID: 6784979 [Abstract] [Full Text] [Related]
38. [Retrobulbar irradiation of endocrine ophthalmopathy: a comparison between 10 and 16 Gy total dose]. Pfluger T, Wendt T, Toroutoglou N, Pickardt C, Wuttge R. Strahlenther Onkol; 1990 Oct 16; 166(10):673-7. PubMed ID: 2237752 [Abstract] [Full Text] [Related]